Aehr Test Systems (NASDAQ:AEHR) Upgraded at Freedom Capital

Freedom Capital upgraded shares of Aehr Test Systems (NASDAQ:AEHR) from a hold rating to a strong-buy rating in a research note published on Thursday,Zacks.com reports.

Other analysts have also recently issued research reports about the stock. Craig Hallum reissued a “buy” rating and issued a $125.00 price target on shares of Aehr Test Systems in a research note on Wednesday. Lake Street Capital reaffirmed a “buy” rating and set a $110.00 price target on shares of Aehr Test Systems in a research report on Wednesday. Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday. Finally, Weiss Ratings cut Aehr Test Systems from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $117.50.

Aehr Test Systems Trading Down 3.7%

Aehr Test Systems stock opened at $81.05 on Thursday. Aehr Test Systems has a 12-month low of $14.99 and a 12-month high of $126.62. The stock has a market cap of $2.55 billion, a P/E ratio of -337.69 and a beta of 3.17. The company has a 50-day moving average price of $94.10 and a 200 day moving average price of $61.57.

Insider Activity at Aehr Test Systems

In other Aehr Test Systems news, Director Howard T. Slayen sold 6,819 shares of Aehr Test Systems stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $104.73, for a total transaction of $714,153.87. Following the completion of the sale, the director directly owned 169,709 shares in the company, valued at $17,773,623.57. This trade represents a 3.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Alistair N. Sporck sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 22nd. The shares were sold at an average price of $93.50, for a total transaction of $187,000.00. Following the completion of the sale, the vice president directly owned 5,177 shares in the company, valued at $484,049.50. This trade represents a 27.87% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 57,825 shares of company stock worth $5,517,987. 6.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Aehr Test Systems

A number of hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada raised its position in Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after buying an additional 1,344 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Aehr Test Systems by 7.9% in the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after buying an additional 1,145 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Aehr Test Systems by 110.8% in the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after buying an additional 3,617 shares in the last quarter. Finally, Rhumbline Advisers raised its holdings in shares of Aehr Test Systems by 3.1% in the 2nd quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after buying an additional 1,254 shares during the period. Hedge funds and other institutional investors own 69.69% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.